Now showing items 1-3 of 3

    • Long-Term Outcomes on Antiretroviral Therapy in a Large Scale-Up Program in Nigeria 

      Meloni, Seema T.; Chang, Charlotte A.; Eisen, Geoffrey; Jolayemi, Toyin; Banigbe, Bolanle; Okonkwo, Prosper I.; Kanki, Phyllis J. (Public Library of Science, 2016)
      Background: While there has been a rapid global scale-up of antiretroviral therapy programs over the past decade, there are limited data on long-term outcomes from large cohorts in resource-constrained settings. Our objective ...
    • A modified anthrax toxin-based enzyme-linked immunospot assay reveals robust T cell responses in symptomatic and asymptomatic Ebola virus exposed individuals 

      Herrera, Bobby Brooke; Hamel, Donald J.; Oshun, Philip; Akinsola, Rolake; Akanmu, Alani S.; Chang, Charlotte Ajeong; Eromon, Philomena; Folarin, Onikepe; Adeyemi, Kayode T.; Happi, Christian T.; Lu, Yichen; Ogunsola, Folasade; Kanki, Phyllis Jean (Public Library of Science (PLoS), 2018)
      Background Ebola virus (EBOV) caused more than 11,000 deaths during the 2013–2016 epidemic in West Africa without approved vaccines or immunotherapeutics. Despite its high lethality in some individuals, EBOV infection can ...
    • Time-Dependent Predictors of Loss to Follow-Up in a Large HIV Treatment Cohort in Nigeria 

      Meloni, Seema Thakore; Chang, Charlotte; Chaplin, Beth; Rawizza, Holly; Jolayemi, Oluwatoyin; Banigbe, Bolanle; Okonkwo, Prosper; Kanki, Phyllis (Oxford University Press, 2014)
      Background: Most evaluations of loss to follow-up (LTFU) in human immunodeficiency virus (HIV) treatment programs focus on baseline predictors, prior to antiretroviral therapy (ART) initiation. As risk of LTFU is a continuous ...